European Journal of Medical Genetics

Scope & Guideline

Pioneering Research in Medical Genetics for Global Impact

Introduction

Delve into the academic richness of European Journal of Medical Genetics with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1769-7212
PublisherELSEVIER
Support Open AccessNo
CountryFrance
TypeJournal
Convergefrom 2005 to 2024
AbbreviationEUR J MED GENET / Eur. J. Med. Genet.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The European Journal of Medical Genetics focuses on advancing the understanding of genetic conditions, their clinical implications, and the methodologies for diagnosis and treatment. It serves as a collaborative platform for researchers and healthcare providers to share insights and findings that can enhance the management of genetic disorders.
  1. Genetic Disorders and Syndromes:
    The journal extensively covers a wide range of genetic disorders, including rare diseases, syndromes, and chromosomal abnormalities, providing insights into their clinical presentations, genetic underpinnings, and management strategies.
  2. Clinical Genetics and Genomic Medicine:
    A significant focus is placed on clinical genetics, including the application of genomic technologies such as next-generation sequencing (NGS) in diagnosing genetic conditions, evaluating variants of uncertain significance, and exploring genotype-phenotype correlations.
  3. Patient-Centered Research and Healthcare:
    Research that emphasizes patient experiences, clinical outcomes, and quality of life for individuals with genetic disorders is a core area, highlighting the importance of patient perspectives in genetic counseling and treatment.
  4. Ethics and Policy in Genetic Testing:
    The journal addresses ethical considerations in genetic testing, including informed consent, disclosure of genetic risks, and the implications of genetic information on family dynamics and healthcare practices.
  5. Emerging Genetic Technologies and Therapies:
    The European Journal of Medical Genetics also explores novel genetic therapies and diagnostic technologies, emphasizing their potential impact on patient care and the future of personalized medicine.
The European Journal of Medical Genetics has identified several emerging themes that reflect the current trends in genetic research and clinical practice. These trends highlight the journal's responsiveness to the evolving landscape of medical genetics and the increasing importance of personalized medicine.
  1. Integration of Genomic Technologies:
    There is a growing emphasis on the application of advanced genomic technologies, such as NGS and whole-genome sequencing, in clinical settings to improve diagnostic accuracy and facilitate personalized treatment plans.
  2. Focus on Rare Genetic Disorders:
    An increasing number of studies are dedicated to rare genetic disorders, which often lack sufficient research and understanding, thereby addressing a critical gap in the field of medical genetics.
  3. Patient-Centric Research:
    Research that prioritizes patient perspectives, experiences, and outcomes is on the rise, reflecting a shift towards more holistic approaches in managing genetic conditions and enhancing the quality of care.
  4. Ethical and Social Implications of Genetic Testing:
    As genetic testing becomes more prevalent, there is an emerging focus on the ethical, social, and psychological implications of test results, including issues related to consent, privacy, and familial relationships.
  5. Telemedicine and Remote Genetic Counseling:
    The COVID-19 pandemic has accelerated the integration of telemedicine in genetic counseling, leading to increased research on its effectiveness, accessibility, and impact on patient engagement and satisfaction.

Declining or Waning

While the journal has consistently published high-quality research on genetic disorders, certain themes appear to be declining in focus over recent years. This may reflect shifts in research priorities or advancements in genetic technologies that have rendered previous approaches less prominent.
  1. Traditional Cytogenetic Techniques:
    There is a noticeable decrease in publications focusing solely on traditional cytogenetic methods, such as karyotyping and FISH, as newer genomic technologies like whole-exome sequencing and NGS have become the standard for genetic analysis.
  2. Generalized Genetic Counseling Approaches:
    Research centered on generalized or traditional genetic counseling methods is waning, with a shift towards more personalized and tailored approaches that consider individual patient circumstances and preferences.
  3. Focus on Common Genetic Disorders:
    The journal's emphasis appears to be moving away from common genetic disorders, such as cystic fibrosis or sickle cell disease, towards rare and complex genetic conditions, reflecting a broader interest in under-researched areas.
  4. Basic Genetic Mechanisms:
    There is a decline in studies that primarily discuss basic genetic mechanisms without clinical implications, as the journal increasingly prioritizes research that directly informs clinical practice and patient outcomes.

Similar Journals

Neurology-Genetics

Bridging the Gap Between Neurology and Genetics.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2376-7839Frequency: 6 issues/year

Neurology-Genetics, an esteemed journal published by LIPPINCOTT WILLIAMS & WILKINS, is at the forefront of advancing the fields of neurology and genetics. With a dedicated Open Access model since 2015, this journal ensures that cutting-edge research is readily available to researchers, professionals, and students worldwide. Operating from the United States, Neurology-Genetics has established a reputable position within the scientific community, as reflected by its impressive rankings in Scopus; it holds a Q1 ranking in clinical neurology and a Q2 ranking in clinical genetics, showcasing its dual commitment to these intertwined fields. With an impact factor that continues to grow alongside its reach, the journal encourages the dissemination of novel findings, innovative methodologies, and critical reviews that contribute to the understanding and treatment of neurological and genetic disorders. Researchers and practitioners are invited to engage with the latest discoveries and discussions, making Neurology-Genetics an essential resource for anyone involved in these dynamic areas of study.

Journal of Pediatric Genetics

Advancing Insights in Pediatric Genetics
Publisher: GEORG THIEME VERLAG KGISSN: 2146-4596Frequency: 4 issues/year

Journal of Pediatric Genetics, published by GEORG THIEME VERLAG KG, is an essential resource in the field of pediatric medicine and genetics. With a focus on the genetic determinants of health and disease in children, this journal aims to advance the knowledge and application of genetic research in pediatric care. Although it has faced challenges in its indexing in recent years, it provides an important platform for practitioners and researchers dedicated to understanding the complexities of pediatric genetics. As evidenced by its position in Scopus ranks—ranked #209 in Pediatrics and #87 in Clinical Genetics—the journal serves a niche yet critical audience seeking to explore the interplay between genetic factors and childhood health outcomes. The Journal of Pediatric Genetics invites scholars and professionals to delve into its rich content, contributing to the ongoing discourse in this vital field, while the absence of open access highlights the journal’s curation of high-quality, peer-reviewed articles that are valued across academia and clinical practices.

GENETICS

Illuminating the Pathways of Genetic Science
Publisher: GENETICS SOCIETY AMERICAISSN: 0016-6731Frequency: 12 issues/year

GENETICS, published by the Genetics Society of America, stands as a preeminent journal in the field of genetics, with a keen focus on advancing the understanding of genetic principles and their implications across various biological systems. Since its inception in 1945, the journal has played a pivotal role in disseminating groundbreaking research, maintaining a Q1 ranking in the genetics category as of 2023, positioning it among the top tier of academic publications. While access to the journal is not open, it continues to attract a global readership of researchers, professionals, and students eager to engage with high-quality, peer-reviewed articles that span both classical and contemporary genetics. With its publication history covering critical decades from 1945 to 2024, GENETICS is not just a repository of scientific knowledge but a vibrant forum for the exchange of ideas that drive the field forward. The journal’s commitment to excellence is demonstrated by its strategic coverage of pertinent topics, assuring its relevance for future generations of scholars.

JOURNAL OF HUMAN GENETICS

Exploring the Frontiers of Human Genetics
Publisher: SPRINGERNATUREISSN: 1434-5161Frequency: 12 issues/year

Welcome to the Journal of Human Genetics, a premier publication in the field of human genetics, published by SpringerNature. With a commitment to sharing groundbreaking research, this journal has been at the forefront of genetic studies since its establishment in 1961, converging its focus in 1996 and continuing to evolve through 2024. It holds a respected Q2 ranking in both the Genetics and Clinical Genetics categories, reflecting its significant contribution to the scientific community. With a notable Scopus ranking of 23rd out of 99 in Clinical Genetics and 95th out of 347 in Genetics, the journal offers a platform for high-impact research that informs clinical practices and advances the understanding of genetic disorders. Operating under an open-access model, it ensures that findings are readily accessible to researchers, professionals, and students worldwide. Join us in exploring the complexities of human genetics and contribute to the ongoing discourse in this dynamic field.

npj Genomic Medicine

Innovating Genomic Solutions for Global Health
Publisher: NATURE PORTFOLIOISSN: Frequency: 1 issue/year

npj Genomic Medicine is a leading open-access journal published by NATURE PORTFOLIO, specializing in the rapidly evolving areas of genomic medicine, including genetics, molecular biology, and clinical applications. Launched in 2016, the journal has quickly established itself within the academic community, boasting a prestigious Q1 ranking in multiple categories, including Genetics and Molecular Biology, with remarkable positions in both Scopus ranks and percentiles. With an emphasis on innovative genomic research that bridges the gap between laboratory findings and clinical implementation, npj Genomic Medicine aims to provide a platform for researchers, professionals, and students to share significant advancements and insights. Being an open-access journal enhances accessibility to cutting-edge research, ensuring that vital discoveries in genomics can benefit a global audience and facilitate interdisciplinary collaboration. The journal continues to contribute to the forefront of genomic research, impacting both academic scholarship and practical healthcare solutions.

NEUROGENETICS

Advancing Insights at the Crossroads of Genetics and Neuroscience
Publisher: SPRINGERISSN: 1364-6745Frequency: 4 issues/year

NEUROGENETICS is a distinguished journal published by SPRINGER, focusing on the intersection of genetics and neuroscience. With its ISSN 1364-6745 and E-ISSN 1364-6753, this journal has been a vital resource in the fields of cellular and molecular neuroscience and genetics since its establishment in 1997. As of 2023, it is ranked Q3 in Cellular and Molecular Neuroscience and Q2 in both Genetics and Clinical Genetics, reflecting its growing influence and importance in these areas. Although not an open-access journal, it provides significant insights and research findings that contribute to advancing our understanding of genetic influences on neural function and disease. Based in Germany with an address at ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, NY 10004, UNITED STATES, NEUROGENETICS serves as a crucial platform for researchers, professionals, and students alike to explore innovative studies that are essential for the future of neuroscience and genetics. With its continuous commitment to high-quality research, the journal aims to foster collaboration and knowledge dissemination among the scientific community.

Medizinische Genetik

Pioneering Insights into Genetic Disorders.
Publisher: WALTER DE GRUYTER GMBHISSN: 0936-5931Frequency: 4 issues/year

Medizinische Genetik is a distinguished academic journal, published by Walter de Gruyter GmbH, that serves the field of medical genetics, offering insights and developments in both clinical and laboratory settings. Since its inception in 1994, the journal has provided a platform for researchers and professionals to disseminate their findings, contributing significantly to scientific discourse in genetics. Although currently listed in the Q4 category for both Genetics and Clinical Genetics according to the 2023 rankings, it remains a vital resource for those looking to understand the evolving landscape of medical genetics. This peer-reviewed journal is accessible through various academic platforms, fostering collaboration and knowledge sharing among academics, clinicians, and students alike. As the journal converges towards 2024, it continues to solidify its role in enhancing the understanding of genetic disorders and innovations in genetic research.

PRENATAL DIAGNOSIS

Leading the Way in Prenatal Research Excellence
Publisher: WILEYISSN: 0197-3851Frequency: 13 issues/year

PRENATAL DIAGNOSIS is an esteemed journal dedicated to the fields of genetics and obstetrics, published by Wiley. With an ISSN of 0197-3851 and E-ISSN of 1097-0223, this journal has been a leading platform for the dissemination of pioneering research since its inception in 1980. Operating from its base in the United Kingdom, PRENATAL DIAGNOSIS has achieved notable recognition, attaining a Q2 category in Genetics (Clinical) and a prestigious Q1 category in Obstetrics and Gynecology as of 2023. It ranks 41st out of 209 in Obstetrics and Gynecology and 40th out of 99 in Clinical Genetics according to Scopus, placing it in the 80th and 60th percentiles, respectively. This journal provides a critical resource for researchers, healthcare professionals, and students who are focused on advancing the science of prenatal diagnosis and its application in clinical practice. While not an open access journal, the content is pivotal for those aiming to engage with the most current findings and methodologies in prenatal care. As it looks toward 2024 and beyond, PRENATAL DIAGNOSIS continues to strive for excellence in fostering breakthroughs that impact maternal and fetal health.

INTERNATIONAL JOURNAL OF HUMAN GENETICS

Advancing the Frontiers of Human Genetics
Publisher: KAMLA-RAJ ENTERPRISESISSN: 0972-3757Frequency: 4 issues/year

INTERNATIONAL JOURNAL OF HUMAN GENETICS is a distinguished publication dedicated to advancing knowledge in the fields of genetics and molecular biology. Published by KAMLA-RAJ ENTERPRISES, this journal explores critical developments and research findings from 2008 to 2016, though its coverage in Scopus has since been discontinued. With an ISSN of 0972-3757 and an E-ISSN of 2456-6330, the journal aimed to foster scholarly dialogue and serve as a resource for researchers, professionals, and students engaged in human genetics. While the journal holds a modest ranking in categories such as Biochemistry and Genetics, it remains a vital source for exploring niche topics within the realm of human genetics. Researchers interested in genetic screening, gene therapy, and clinical genetics will find valuable insights herein. Despite its pause in indexing, the journal continues to contribute to the academic discourse by disseminating critical research that bridges gaps in understanding human genetics.

Molecular Genetics & Genomic Medicine

Empowering the future of genomic medicine.
Publisher: WILEYISSN: 2324-9269Frequency: 12 issues/year

Molecular Genetics & Genomic Medicine, published by WILEY, is an esteemed and open-access journal that has been a prominent source of knowledge in the fields of genetics and molecular biology since its establishment in 2013. With an ISSN of 2324-9269, it aims to provide a platform for the dissemination of novel findings and innovative research that pushes the boundaries of genomics and its clinical applications. The journal holds a Q3 categorization in Genetics, Clinical Genetics, and Molecular Biology, reflecting its growing influence in these disciplines, as evidenced by its Scopus rankings. Researchers, professionals, and students alike will find valuable insights and advancements in genomic medicine, making this journal an essential resource for those dedicated to the understanding and application of genetic and molecular research in healthcare. Located at 111 River St, Hoboken, NJ, Molecular Genetics & Genomic Medicine continues to foster a global dialogue within the scientific community, ensuring accessible knowledge for all.